3,100
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

GRP78-targeted and doxorubicin-loaded nanodroplets combined with ultrasound: a potential novel theranostics for castration-resistant prostate cancer

ORCID Icon, , , , , , , ORCID Icon & show all
Pages 203-213 | Received 27 Oct 2021, Accepted 20 Dec 2021, Published online: 05 Jan 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yushen Jin, Zhongquan Cheng, Zhu Yuan, Yang Du, Jie Tian & Bing Shao. (2024) Glucose-Regulated Protein 78 Targeting ICG and DOX Loaded Hollow Fe3O4 Nanoparticles for Hepatocellular Carcinoma Diagnosis and Therapy. International Journal of Nanomedicine 19, pages 189-208.
Read now

Articles from other publishers (10)

Guodong Yang, Yu Cao, Xinyi Yang, Te Cui, Nicole Zian Vi Tan, Yuen Kai Lim, Yu Fu, Xinren Cao, Aanchal Bhandari, Mikhail Enikeev, Sergey Efetov, Vladimir Balaban & Mingze He. (2024) Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies – Spotlight on prostate and colorectal cancer. Experimental and Molecular Pathology 137, pages 104904.
Crossref
Hongyu Tang, Zhijie Wang, Haoyang Hao, Weixian Luo, Jingru Yang, Mengyao Li, Mingxin Yang, Ziteng Chen, Ruyu Yan, Hao Li, Fan Hu, Haojun Liang, Qiuyang Liu, Linwen Lv, Junhui Zhang, Wenxi Su, Ranran Chen, Kui Chen, Ya-nan Chang, Meng Wang, Lingna Zheng, Xuesong Feng, Juan Li & Gengmei Xing. (2024) Boron-Containing Mesoporous Silica Nanoparticles with Effective Delivery and Targeting of Liver Cancer Cells for Boron Neutron Capture Therapy. ACS Applied Materials & Interfaces.
Crossref
Ruimin Hu, Jin Lan, Dinglin Zhang & Wenhao Shen. (2024) Nanotherapeutics for prostate cancer treatment: A comprehensive review. Biomaterials 305, pages 122469.
Crossref
Yi‐Chang Chiang, Wohn‐Jenn Leu, Yi‐Chin Chen, Pei‐Chen Ye, Yu‐Tung Hsu, Yu‐Chi Hsiao, Jui‐Ling Hsu, She‐Hung Chan, Lih‐Ching Hsu, Hsu‐Shan Huang & Jih‐Hwa Guh. (2023) Mechanistic study of dual‐function inhibitors targeting topoisomerase II and Rad51‐mediated DNA repair pathway against castration‐resistant prostate cancer. The Prostate 83:16, pages 1549-1563.
Crossref
Ayca Ece Nezir, Zeynep Busra Bolat, Naile Ozturk, Polen Kocak, Ebru Zemheri, Sevgi Gulyuz, Umut Ugur Ozkose, Ozgur Yilmaz, Imran Vural, Asuman Bozkır, Fikrettin Sahin & Dilek Telci. (2023) Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI30%-b-PCL polymeric micelle nanocarriers. Amino Acids 55:8, pages 1023-1037.
Crossref
Rajalakshmi Amaresan & Udhayakumar Gopal. (2023) Cell surface GRP78: a potential mechanism of therapeutic resistant tumors. Cancer Cell International 23:1.
Crossref
Ting Li, Jiewen Fu, Jingliang Cheng, Abdo A. Elfiky, Chunli Wei & Junjiang Fu. (2023) New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19. Frontiers in Immunology 14.
Crossref
Yan Gao, Kaiyu Wang, Jin Zhang, Xingmei Duan, Qiu Sun & Ke Men. (2023) Multifunctional nanoparticle for cancer therapy. MedComm 4:1.
Crossref
Hsin-Ying Chen & Ann-Joy Cheng. (2022) Potential to Eradicate Cancer Stemness by Targeting Cell Surface GRP78. Biomolecules 12:7, pages 941.
Crossref
Xudong Li, Yuran Wang, Chenyun Feng, Haijun Chen & Yu Gao. (2022) Chemical Modification of Chitosan for Developing Cancer Nanotheranostics. Biomacromolecules 23:6, pages 2197-2218.
Crossref